“This is the question, the ultimate question, the eternal question. If we are people of faith, this arrow must be shot through every decision and action in our small lives and in our vast world.”
Laura Kelly Fanucci: What would God do?
Author calls for greater respect of human dignity in health care
“This is an essential read for anyone put in the position, however reluctantly, of being the family caretaker. Camosy seeks to bring hope as well as comfort, and he makes an intelligent, trenchant argument for keeping one’s moral decisions intact and without compromise.”
COVID-19 vaccines present ‘no ethical problem,’ says head of papal academy
The Vatican has reaffirmed its support of COVID-19 vaccines with both the head of the Pontifical Academy for Life and a Holy See communique reiterating Pope Francis’ insistence that getting inoculated is “an act of love.”
Bishop Kettler addresses moral questions surrounding COVID-19 vaccines
“It is morally permissible to receive any of the three vaccines — Pfizer, Moderna or Johnson & Johnson — currently being shipped around the country.”
Bishops address concern over Johnson & Johnson vaccine’s abortion link
Use of the Johnson & Johnson COVID-19 vaccine, approved Feb. 27 by the U.S. Food and Drug Administration, raises moral concerns because it was “was developed, tested and is produced with abortion-derived cell lines,” the chairmen of two U.S. bishops committees said March 2.
Widespread vaccination, supported by pope, faces myriad obstacles
The hurdles on the path toward a fair, global distribution of the COVID-19 vaccine are economic, technical, political and moral.
Vatican: Without alternatives, current COVID-19 vaccines are morally acceptable
The Vatican’s doctrinal office said that when alternative vaccines are not available, it is morally acceptable to receive COVID-19 vaccines developed or tested using cell lines originating from aborted fetuses.
Bioethics questions emerge from experimental drug used in COVID-19 treatment
The treatment that President Donald Trump has received to fight COVID-19 has turned the focus on an experimental drug that shows promise in combating the coronavirus but is raising ethical questions about the cell line that helped researchers develop the medicine.